Effectiveness of the Quotient® ADHD Assessment in a System of Care

Attention Deficit Disorder With Hyperactivity Clinical Trial

Official title: Effectiveness of the Quotient® ADHD Assessment in a System of Care

Status Terminated

Clinical Trial Summary

The study goal is to examine whether the use of an objective computerized neuroassessment (the Quotient System) for Attention-Deficit/Hyperactivity Disorder (ADHD) is related to improved outcomes among pediatric patients being assessed and treated for ADHD.

Clinical Trial Description

This study is a randomized, controlled trial using a 2-phase data collection. The first phase is the initial assessment for ADHD and includes all patients eligible to be assessed for ADHD as determined by their clinician in the course of usual care. The baseline measurements will be used to compare groups at baseline, and also for longitudinal analyses of medication management. Patients are randomized at this point. Patients in both treatment arms who then receive an ADHD diagnosis and who start medication for ADHD will be eligible for the second phase of the study: three follow-up assessments over six months. Patients who do not have an ADHD diagnosis will not continue in the study, and will be treated by their clinician as usual. ;

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label

Related Conditions & MeSH terms

• Attention Deficit and Disruptive Behavior Disorders
• Attention Deficit Disorder With Hyperactivity
• Disease
• Hyperkinesis
• Mental Disorders

• NCT number: NCT02094612
• Study type: Interventional
• Source: Kaiser Permanente
• Status: Terminated
• Phase: N/A
• Start date: March 2014
• Completion date: August 2015